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ABSTRACT
Objective: The present study is aimed to find a three simple, low cost, accurate, rapid, and sensitive spectrophotometric methods based on the 
formation of ternary complexes to assay methyldopa (MTD) in both pure and pharmaceutical dosage forms.
Methods: The suggested complexation procedure is based on the formation of ternary complex among MTD, 2-aminopyridine (2-Amp), and different 
metal cations such as [Fe(III), Mn(II), and Co(II)] to form three complexes of Fe(III)-MTD-2-Amp (A), Mn(II)-MTD-2-Amp (B), and Co(II)-MTD-2-Amp 
(C) in an aqueous medium.
Results: The obtained colored complexes are spectrophotometrically measured for the previously mentioned complexes at 572, 473, and 465 nm, 
respectively. Under optimum conditions, the complexes exhibited apparent, molar absorptivities of 1810.62, 2954.18, and 2596.8 l/mol/cm, Sandell’s 
sensitivity of 0.132, 0.08, and 0.092 µg/cm2, and Beer–Lambert’s law is obeyed over the ranges 4–40, 4–32, and 4–40 µg/ml for the three developed 
methods, respectively.
Conclusion: The developed spectrophotometric methods showed excellent results in regard to accuracy and precision with recovery of 99.48±1.62%, 
100.24±1.76%, and 100.72±1.65% of the complexes A, B, and C, respectively. The obtained results are compared statistically with a reported method 
with respect to t- and F-tests and the calculated results displayed no significant difference.
Keywords: Methyldopa, Ternary complex, Mixed-ligand, Spectrophotometry.
INTRODUCTION
Methyldopa (MTD) is a catecholamine derivative that recommended for 
the treatment of hypertensive disease. It is one of the most preferred 
antihypertensive medications in pregnancy, particularly in complicated 
cases of pregnancy and renal failure. Due to, it does not affect both 
uterine and placental circulations, it maintains the renal blood flow [1,2], 
chemically, known as 3-hydroxy-a-methyl-L-tyrosine sesquihydrate 
(Fig. 1). Its antihypertensive characteristic is primarily assigned to 
mislead the alpha-adrenoreceptors in the lower brain stem to accept 
its metabolitea-methyl-norepinephrine instead of norepinephrine and 
causes neurotransmitter stimulation to reduce nervous sympathetic 
and leads to lower of the blood pressure [3].
The literature survey reported several analytical methods to 
determine MTD. Among these methods, high-performance 
liquid chromatography [4], liquid chromatography coupled 
with mass spectrometry [5], electrochemical methods [6-9], 
chemiluminescence [10], and other techniques [11,12]. The ternary 
complex formation has been considered to be of an important role 
in the field of spectrophotometric analysis [13,14]; they are divided 
into two types, ion-association and a mixed-ligand complex. Different 
pharmaceutical compounds have been analyzed using ion-pair 
complexes [15,16]. Meanwhile, the formation of ternary complexes 
starts to get much attention [17,18]. By increasing the demand for the 
more sensitive reagents, the attempts have been made to intensify the 
color using a third component like metal ions to form a ternary complex. 
Large bathochromic shift due to deep color formation is observed by 
the addition of specific metal ions to decolorized solutions, and high 
absorbance at a shifted wavelength will result in an increase in molar 
absorptivity and sensitivity.
Although the reported methods indicated that different analytical 
techniques have been employed to determine MTD, the present study 
aims to suggest a simple and fast spectrophotometric method based on 
the formation of ternary Complexes of MTD,  2-Amp and different metal 
cations such as Fe(III), Mn(II), and Co(II) in an aqueous medium. The 
suggested method is exploited to determine the MTD in its bulk powder 
and pharmaceutical dosage forms.
EXPERIMENTAL
Physical measurements
All spectrophotometric measurements are carried out using a Shimadzu 
spectrophotometer (Model UV-1800) dual beam with 1.0 cm matched 
quartz cells. Infrared spectra data are recorded on a Shimadzu FTIR-
8400S (4000-400 cm-1) using KBr discs.
Chemicals and reagents
All chemicals used are of analytical grade and used without further 
purification. Deionized water is used throughout all the experiments. 
A stock solution of 1000 µg/ml, 4.19×10−3 mol/l) of MTD standard is 
kindly supplied by the state company of Drugs Industry and Medical 
Appliances (Samarra, Iraq). A freshly prepared solutions of each 
(1000 µg/ml, 6.16×10−3 mol/l) of Iron(III) chloride (BDH, pool, UK) 
(1000 µg/ml, 5.05×10−3 mol/l) of Manganese(II) chloride hexahydrate 
(Fluka, Switzerland), (1000 µg/ml, 4.2×10−3  mol/l) of Cobalt(II) 
© 2019 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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Fig. 1: Structure of methyldopa
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chloride hexahydrate (Merck), and (0.1 mol/l) of 2-Amp (Merck) are 
used. Furthermore, 0.1 mol/l of sodium hydroxide (BDH, pool, UK) 
and 37% of hydrochloric acid (Fluka, Switzerland) are also prepared. 
All the materials for the interference study are from (Sigma-Aldrich, 
Hamburg, Germany). A solution (1000 µg/ml, 4.19×10−3  mol/l) of 
two brands of Aldosam (SDI, Samarra, Iraq) and Aldomet (Algorithm 
pharmaceutical company, Lebanon) labeled 250 mg/tablet, each one 
is prepared by dissolving an amount equivalent to 100 mg of MTD 
in a 100 ml of volumetric flask and diluted to mark with water, then 
filtered. Solutions of less concentrations are prepared by appropriate 
dilution.
Standard procedure for the assay of methyldopa
*For complex (A), a series of solutions containing 4.0–40 µg/mlof MTD, 
0.8 ml of 6.16×10−3 mol/l Fe(III) solution, and 0.8 ml of 0.1 mol/lof 
2-Amp solution, the mixture is diluted to 10 ml with deionized water, 
mixed well, and kept at room temperature for 10 min.
*For complex (B), a series of solutions containing 4.0–32 µg/mlof MTD, 
0.8 ml of 5.05×10−3 mol/lMn(II) solution, and 1.0 ml of 0.1 mol/l2-Amp 
solution is prepared. The mixture is diluted to 10 ml with deionized 
water, mixed well, and kept at 60°C for 30 min in a thermostatically 
controlled water bath.
*For complex (C), a series of solutions containing 4.0–40 µg/mlof MTD, 
1.2 ml of 4.2×10−3 mol/l Co(II) solution, and 1.4 ml of 0.1 mol/l2-Amp 
solution, the mixture is diluted to 10 ml with water, mixed well, and 
kept at 60°C for 20 min in a thermostatically controlled water bath. 
After thermostatic control, solutions of complex B and C are cooled 
down in water to room temperature. The absorbance of these solutions 
is measured at 572, 473, and 465 nm, respectively.
RESULTS AND DISCUSSION
Optimization of analytical conditions
The analytical conditions for the proposed spectrophotometric method 
are investigated and optimized. The suitable volumes of each reacted 
2-Amp reagent and the added metal solution are tested in the range 
of 0.2–2.0 ml for the proposed systems A, B, and C, using fixed MTD 
concentrations 20, 4, and 4 µg/ml, respectively. The recorded data 
revealed that the suitable volumes of added metals are 0.6, 0.8, and 
1.2 ml of Fe(III), Mn(II), and Co(II), respectively (Fig. 2a). Additionally, 
the highest absorbance is observed using 0.8, 1.0, and 1.4 ml of the 
reagent 2-Amp for the previously mentioned systems (Fig. 2b).
The effect of the order of the reagent addition on the performance of 
the spectrophotometric measurement is investigated. As presented in 
Table 1, the best absorbance is obtained when using the order MTD + 
Metal + 2-Amp.
Since the addition of a small amount of acid or base is found to decrease 
the absorbance value which can be attributed to the decomposition or 
change the structure of a ternary complex so the addition of any acid or 
base is avoided.
Furthermore, the influence of temperature on the absorbance 
measurements is studied. Fig. 3 shows that at 5–20°C, the absorbance 
of Fe-MTD-2Amp complex is increased and a plateau between 20 
and 35°C, then the decrease in absorbance is observed between 35 
and 70°C. For the Mn and Co complexes, an increase in absorbance is 
noticed with increasing the temperature.
Finally, the stability time of the formed complexes is studied and it 
is noticed that the absorbance of the complex A is decreased up to 
10 min and still constant for 24 h. Meanwhile, in both of complex B 
and complex C, the color does not develop instantaneously at room 
temperature. Thus, the effect of temperature is also investigated by 
incubating the formed complexes B and C at 40, 45, 50, 55, and 60°C for 
Fig. 3: Effect of temperature on the complexes formation
Table 1: The obtained results using different orders of addition






MTD+metal+2-Amp 0.153 0.063 0.042
2-Amp+MTD+Metal 0.080 0.053 0.019
Metal+2-Amp+MTD 0.021 0.059 0.025
MTD: Methyldopa, 2-Amp: 2-aminopyridine
Fig. 2: (a and b) Selection of the suitable volumes of reacting reagent 2‑aminopyridine and the added metal ion
ba
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15–40 min; a constant absorbance is obtained at 55°C for 30 min for the 
complex band at 60°C for 20 min for the complex C (Fig. 4).
Under optimum conditions, the determination of MTD using the 
suggested spectrophotometric method is performed using a fixed 
concentration of 20, 4, and 4 µg/ml of MTD for A, B, and C systems, 
respectively (Fig. 5).
Calibration curve
The calibration graphs of the three suggested systems A, B, and C are 
constructed by plotting the absorbance vs. the MTD concentrations 
(Fig. 6). The critical response data are presented in Table 2. The 
percentage recoveries are 99.48, 100.24, and 100.72% with limits of 
detection [19] 0.152, 0.256, and 0.282 µg/ml and quantification limits 
0.46, 0.776, and 0.853 µg/mlfor systems A, B, and C, respectively.
Interferences
The effect of some foreign inorganic ions and the most common 
excipients used in the dosage formulations on the assay of a fixed 
concentration of MTD (20 µg/ml) is studied. As indicated in Table 3, 
no significant interferences are recorded. Therefore, the suggested 
spectrophotometric systems are suitable for the determination of the 
investigated drug.
Analytical applications
The proposed spectrophotometric systems are applied for the 
determination of MTD in pharmaceutical tablets (Aldosam, Aldomet). 
The results are presented in Table 4 and compared with the results 
obtained from a previously published method [20] using Student’s 
t-test and variance ratio F-test. To prove the accuracy of the suggested 
method, the standard addition method (Figs. 7 and 8, Table 5) is also 
employed to analyze the investigated drug. This method included the 
addition of fixed amount (8 μg/ml) of either Aldosam or Aldomet and 
0,  4,  8,  and  12  μg/ml  of  standard MTD  solution  in  a  series  of  10 ml 
volumetric flasks. The solutions are treated as in calibration graph 
procedure. The obtained results showed excellent accuracy. Moreover, 
intraday and interday assays are applied for studying the precision of the 
present method by the determination of three different concentrations 
Fig. 4: Effect of the stability time on the formed ternary complexes
Fig. 5: Ultraviolet‑Vis spectra of the formed complexes under 
optimum conditions
Fig. 6: Calibration graphs of the suggested systems
Fig. 7: Standard additions method for assay of Aldosam
Table 2: Analytical data obtained from the assay of methyldopa 
using the proposed spectrophotometric methods
Parameter Complex A Complex B Complex C
Linearity, µg/ml 4–40 4–32 4–40
Slope, a 0.0076 0.0124 0.0109
Intercept, b 0.0003 0.0135 0.0016
Correlation coefficient, R2 0.9975 0.9981 0.9997
Molar absorptivity (ε) l/mol/cm 1810.62 2954.18 2569.80
Sandell’s sensitivity, µg cm2 0.132 0.080 0.092
RSD % 1.64 1.67 1.65
Mean recovery % 99.48 100.24 100.72
LOD, µg/ml 0.152 0.256 0.282
LOQ, µg/ml 0.460 0.776 0.853
LOD: Limit of detection, LOQ: Limit of quantitation, RSD: Relative standard deviation
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Table 3: The effect of foreign substances on the assay of methyldopa
Substance Molar ratio MTD: Substance Recovery percentage
For Fe‑MTD‑2‑Amp For Mn‑MTD‑2‑Amp For Co‑MTD‑2‑Amp
Ca+2 87.4 95.25 96.5 95
Zn+2 87.4 100 100 100
Na+ 203.7 100 100 100
Cd+2 65 100 100 100
Ascorbic acid 90 100 100 100
Glucose 100 100 100 100
Fructose 100 100 100 100
Lactose 190 100 100 100
Sucrose 180 100 100 100
Starch (mg) 1.0 100 100 100
Talc 31.4 100 100 100
Polyethylene glycol (mg) 10 100 100 100
Microcrystalline cellulose (mg) 1.0 100 100 100
Croscarmellose sodium 12 100 100 100
Polyvinylpyrrolidone (mg) 1.0 100 100 100
Magnesium stearate 20 100 100 100
MTD: Methyldopa, 2-Amp: 2-aminopyridine
of MTD in pure form through three consecutive occasions or by 
replicating the analysis for a period of 3 consecutive days. The value 
of % relative standard deviation ranged from 0.3 to 0.5% for intraday 
and 0.2%–0.7% for interday assays, revealing good precision for the 
proposed method and it can be applied for the assay of MTD.
Stoichiometry of the reaction
Job’s method of continuous variation is used to study the stoichiometry 
of the reaction; the ratio of MTD to the metal is estimated. The results 
Fig. 8: Standard additions method for assay of Aldomet
Fig. 9: Plots of job’s method of continuous variation
Table 4: Assay of methyldopa in pharmaceutical tablets
Pharmaceutical preparation Complex A Complex B Complex C Reported method
Aldosam
Recovery %±SD, (n=6) 100.25±0.47 99.93±0.44 100.73±0.42 99.1±0.26
SE=0.4
n=6
Percentage SE 0.2 0.4 0.3
t-test* 2.05 0.13 1.09
F-test* 1.19 1.43 1.50
Aldomet
Recovery %±SD, (n=6) 100.27±0.38 100.11±0.22 100.21±0.39 100.1±0.29
SE=0.7
n=6
Percentage SE 0.4 0.3 0.1
t-test* 1.77 0.23 1.42
F-test* 2.42 0.55 1.76
*ttab is equal to 2.78 for 4° of freedom at 95% confidence level, Ftab is equal to 19.0 for 2° of freedom at 95% confidence level. SD: Standard deviation, SE: Standard error
Table 5: Results of standard additions method for the determination of methyldopa in pharmaceutical tablets
Pharmaceutical preparations Fe‑MTD‑2‑Amp Mn‑MTD‑2‑Amp Co‑MTD‑2‑Amp
Found, µg/ml Recovery % Found, µg/ml Recovery % Found, µg/ml Recovery %
Aldosam
Taken: 8 µg/ml
7.89 98.63 7.91 98.88 7.92 99
Aldomet
Taken: 8 µg/ml
7.94 99.25 7.95 99.45 7.94 99.25
MTD: Methyldopa, 2-Amp: 2-aminopyridine
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(Fig. 9) showed that the ratio of MTD to Fe(III) (complex A) is 2:1, and 
for both complex B and complex C, the ratio of MTD: Mn and MTD: Co 
is 1:1.The structure of these complexes is clarified by infrared spectra 
of the three complexes and their free ligands. In the spectra of these 
complexes, the band of the OH group of the catechol nucleus (Fig. 10a) 
in MTD molecule is disappeared. Therefore, MTD in all these complexes 
is coordinated to metal as a bidentate ligand, on the other hand, the 
2-Amp molecule (Fig. 10b) is coordinated to metal by two groups, 
first is linked through (–C=N) of 2-Amp ring. This coordination bond 
is found in all these complexes (Fig. 10c-e), where its position in free 
ligand (1595 cm−1) is shifted to lower wave number (1481.31 cm−1). 
The second coordination bond of 2-Amp is attributed to NH2 group of 
2-Amp, and its band is disappeared in both of complex (B) and complex 
(C), another data are found for molecules of water at 3360 cm−1 in both 
of complex (B) and complex (C). Finally, complex (C) displayed two 
bands for (Co–Cl) [21] at (330 cm−1) and (345 cm−1), so the structures 
of the formed complexes can be deduced (Fig. 11a-c) for complex (A) 
as [Fe(2-AMP)2(MTD)2], Complex (B) as [Mn(2-AMP)(H2O)2(MTD)], and 
Complex (C) as [Co(2-AMP)Cl(H2O)(MTD)].
CONCLUSION
The present study focused on the development of a new 
spectrophotometric method for determination of MTD based on the 
formation of ternary complex using three different metal ions by a 
mixed-ligand type. The results obtained revealed high accuracy and 
good reproducibility. The method has been successfully applied for 
determination of MTD in the pharmaceutical tablets (Aldosam and 
Aldomet).
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Fig. 11: The proposed chemical structure of the formed complexes 




Fig. 10: Infrared spectra of (a) methyldopa, (b) 2‑aminopyridine, (c) Fe(III)‑methyldopa‑2‑aminopyridine, (d) Mn (II)‑methyldopa‑2‑
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